Collaboration Partners

Partnerships

We are partners in research networks and consortia granted by the Spanish and EU funding programmes in diverse areas of drug discovery and applied biotechnology.

logo-marbles
logo-openscreen
logo-iimena
ricet
logo-iraadd
logo-imi

 

logo-paramet
logo-marpipe
logo-redefar

 

ocean medicines
logo-blueandgreen
logo-pharmasea

 

 

TOPCAPIlogo2-150x150

 


 

Memberships

sem
asebio
Logo_Biovegen

We are corporate members of national & international scientific societies and biotech sector associations. 

logo-BBIju
logo-beam


Projects

An Integrated Antiviral Discovery Platform of Broad-Spectrum Small Molecule Inhibitors of Viral Targets from Priority Preparedness Pathogens - Res4PrioPath (ISID_JRA_s8mf).

Duration: November 2023 - July 2025

This project has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement number 101046133.

https://isidore-project.eu/

ECOPEST_TECH SOLUTIONS. AEI-010500-2022-32 ASOCIACION CLUSTER GRANADA PLAZA TECNOLOGICA Y BIOTECNOLOGICA (ONGRANADA)
I+D+i de nuevas soluciones tecnológicas para mejorar el uso de biocidas en servicios de control de plagas urbanas, garantizando la protección de la salud humana, la salud animal y el medio ambiente, “ECOPEST_TECH SOLUTIONS”.

Financiado por el Ministerio de Industria, Comercio y Turismo (MINCOTUR) dentro del programa de apoyo a las AEI para contribuir a la mejora de la competitividad de la industria española.

https://www.mincotur.gob.es

 

 

INTEGRATED SERVICES FOR INFECTIOUS DISEASE OUTBREAK RESEARCH (ISIDORe)

HORIZON-INFRA-2021-EMERGENCY-02 Research infrastructure services for rapid research responses to COVID-19 and other infectious disease epidemics.
Duration: 2022 - 2024
This project has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No 101046133.

https://isidore-project.eu/

H2020-FNR-2020 / H2020-FNR-2020-2
MARBLES, Marine Biodiversity as Sustainable Resource of Disease-Suppressive Microbes and Bioprotectants for Aquaculture and Crop Diseases.

Research Executive Agency (REA) EUROPEAN COMISSION.

https://cordis.europa.eu/project/id/101000392/es

 

 

 

PID2020-119559RB-I00 “MEDINAMICINA, UN NUEVO Y POTENTE INHIBIDOR DE LAS TRANSGLICOSILASASBACTERIANAS: BIOSINTESIS, OPTIMIZACION DE SU PRODUCCION Y GENERACION DE ANALOGOS CON MEJOR FARMACOLOGIA”.

CONVOCATORIA 2020 DE «PROYECTOS I+D+i» EN EL MARCO DEL PROGRAMA ESTATAL DE GENERACIÓN DE CONOCIMIENTO Y FORTALECIMIENTO CIENTÍFICO Y TECNOLÓGICO DEL SISTEMA DE I+D+i Y DEL PROGRAMA ESTATAL DE I+D+i ORIENTADA A LOS RETOS DE LA SOCIEDAD.

http://www.aei.gob.es/

 

HR20-00584 HEALTH RESEARCH 2020 LA CAIXA, “Discovery of new antiparasitic drug candidates and innovative modes of actions from Microbial Natural Products”. Health Research 2020. NP4NTD

LA CAIXA Research Consortium Fundación MEDINA, the Drugs for Neglected Diseases initiative (DNDi) and Institut Pasteur Korea.

https://blog.caixaresearch.org/

Health Research 2020. NP4NTD

 

 

RTC2019-007357-1 - Firma Molecular en Biopsia líquida para respuesta a radioterapia y recaída temprana en cáncer de próstata.

Financiado por el Ministerio de Ciencia e Innovación a través de la Agencia Estatal de Investigación.

Proyecto dentro de la Convocatoria Retos-Colaboración 2019.

Liderado por ATRYS HEALTH S.A, participantes: HOSPITAL RECOLETAS CASTILLA Y LEON, ATRYS HEALTH S.A, FUNDACION INSTITUTO ESTUDIOS CIENCIAS DE LA SALUD-CASTILLA Y LEON y Fundación MEDINA

fondos.ciencia.gob.es/portal/site/fondos

 

PY18-FR-0030 - Nueva aproximación para el descubrimiento de compuestos microbianos que induzcan la biosíntesis de nuevos antibióticos en actinomicetos.

Financiado por la Junta de Andalucía y cofinanciado por la Unión Europea a través de los Fondos FEDER.

Proyectos de I+D+i, en régimen de concurrencia competitiva, destinadas a entidades privadas calificadas como Agentes del Sistema Andaluz del Conocimiento, en el ámbito del Plan Andaluz de Investigación, Desarrollo e Innovación (PAIDI 2020)

https://www.juntadeandalucia.es/servicios/procedimientos/detalle/15266/datos-basicos.html

PY18-RE- 0027 - Caracterización de microorganismos asociados a líquenes de afloramientos yesíferos como fuente de metabolitos antimicrobianos frente a fitopatógenos y estudio de sus implicaciones biológicas.

Financiado por la Junta de Andalucía y cofinanciado por la Unión Europea a través de los Fondos FEDER.

Proyectos de I+D+i, en régimen de concurrencia competitiva, destinadas a entidades privadas calificadas como Agentes del Sistema Andaluz del Conocimiento, en el ámbito del Plan Andaluz de Investigación, Desarrollo e Innovación (PAIDI 2020)

https://www.juntadeandalucia.es/servicios/procedimientos/detalle/15266/datos-basicos.html

PY18-RE-0031 - En busca de nuevos antibioticos derivados del nuevo inhibidor de la replicación bacteriana kibdelomicina.

Financiado por la Junta de Andalucía y cofinanciado por la Unión Europea a través de los Fondos FEDER.

Proyectos de I+D+i, en régimen de concurrencia competitiva, destinadas a entidades privadas calificadas como Agentes del Sistema Andaluz del Conocimiento, en el ámbito del Plan Andaluz de Investigación, Desarrollo e Innovación (PAIDI 2020)

https://www.juntadeandalucia.es/servicios/procedimientos/detalle/15266/datos-basicos.html

PY18-RE-0041 - Búsqueda de nuevos inhibidores anti-tumorales procedentes de productos naturales del punto de control inmunitario PD-1/PD-L1 e inhibidores de traslocación nuclear.

Financiado por la Junta de Andalucía y cofinanciado por la Unión Europea a través de los Fondos FEDER.

Proyectos de I+D+i, en régimen de concurrencia competitiva, destinadas a entidades privadas calificadas como Agentes del Sistema Andaluz del Conocimiento, en el ámbito del Plan Andaluz de Investigación, Desarrollo e Innovación (PAIDI 2020)

https://www.juntadeandalucia.es/servicios/procedimientos/detalle/15266/datos-basicos.html

SCREENING (PAIDI 2020) - R + D + i Infrastructure and Equipment Project Ref. IE_18_0031. Funded by Regional Government of Andalucía and co-financed by the European Union through FEDER Funds.

Ayudas a infraestructuras y equipamientos de I+D+i para entidades de carácter privado convocada, en régimen de concurrencia competitiva, en el ámbito del Plan Andaluz de Investigación, Desarrollo e Innovación (PAIDI 2020) y de la Estrategia de Innovación de Andalucía (RIS3 Andalucía).

https://www.juntadeandalucia.es/servicios/procedimientos/detalle/15266/datos-basicos.html

MICROBIOME (PAIDI 2020) - R + D + i Infrastructure and Equipment Project Ref. IE_18_0032. Funded by Regional Government of Andalucía and co-financed by the European Union through FEDER Funds.

Ayudas a infraestructuras y equipamientos de I+D+i para entidades de carácter privado convocada, en régimen de concurrencia competitiva, en el ámbito del Plan Andaluz de Investigación, Desarrollo e Innovación (PAIDI 2020) y de la Estrategia de Innovación de Andalucía (RIS3 Andalucía).

https://www.juntadeandalucia.es/servicios/procedimientos/detalle/15266/datos-basicos.html

CHEMISTRY (PAIDI 2020) - R + D + i Infrastructure and Equipment Project Ref. IE_18_0035. Funded by Regional Government of Andalucía and co-financed by the European Union through FEDER Funds.

Ayudas a infraestructuras y equipamientos de I+D+i para entidades de carácter privado convocada, en régimen de concurrencia competitiva, en el ámbito del Plan Andaluz de Investigación, Desarrollo e Innovación (PAIDI 2020) y de la Estrategia de Innovación de Andalucía (RIS3 Andalucía).

https://www.juntadeandalucia.es/servicios/procedimientos/detalle/15266/datos-basicos.html

 

 

 

PI19/00921 Nuevos antibióticos contra patógenos Gram negativos multirresistentes.

Ayuda financiada por el Instituto de Salud Carlos III convocatoria 2019 de la Acción Estratégica en Salud 2017-2020

www.isciii.es

ANEXO_FINANCIABLES_PI_PRESUPUESTO

 

 

LISSA - New alternatives to the use of disinfectants in the food industry to minimize Listeria monocytogenes and Salmonella enterica survival on food contact surfaces

Grant agreement nº RTI2018-098267-R-C31

The LISSA project aims to minimize pathogen survival on food contact surfaces investigating new antibiofilm materials, and new antibiofilm agents, as alternative methods to the use of disinfectants in the food industry.

 

 

EU-OPENSCREEN-DRIVE - Development and long-term sustainability of new pan-European research infrastructures

Grant Agreement No.: 823893

EU-OS-DRIVE aims to accelerate the implementation of EU-OS and promote the early utilization of the RI. The project will support the implementation of the EU-OS scientific and technical program and the delivery of its main mission: to build a sustainable European infrastructure for chemical biology, supporting life-science research with innovative chemical tools and bioactivity data and the translation to society, environment and medicine.

https://drive.eu-openscreen.eu/drive-startseite.html

IIMENA - Integration of Informatics and Metabolomic Engineering for the discovery of Novels Antibiotics

Funded by the Novo Nordisk Foundation. Duration: 2017 - 2023

The iimena-project aims to integrate state-of-the art screening technologies, bioinformatics and metabolic engineering approches in order to identify and characterize novel secondary metabolites from actinomycetes, which can become lead-candidates for antibiotic drug development.

www.iimena.org

 

Red de Investigación Colaborativa en Enfermedades Tropicales RICET

Ayuda financiada por el Instituto de Salud Carlos III convocatoria 2016 de la Acción Estratégica en Salud 2013-2016
Expediente RD16/0027/0015 Duración 2017-2021

www.isciii.es

 

 

TOPCAPI - Thoroughly Optimised Production Chassis for Advanced Pharmaceutical Ingredients

Funded by: EUROPEAN COMMISSION - Horizon 2020 - NMBP-BIO-2016 - Proposal 720793-2 - Duration (months): 48

TOPCAPI will exploit the natural biosynthetic potential of actinomycetes as microbial cell factories to produce advanced pharmaceutical ingredients: a new anti-acne drug, in Phase II clinical trials, and three related drugs against multidrug resistant bacteria MRSA, in Phase III clinical trials.  For that purpose, two common microbial bacteria will be characterized using systems biology approaches, applying integrated data analysis to transcriptomics and metabolomics experiments, combined with predictive mathematical modelling to drive the rapid improvement of these microbial cell factories for industrial production of these drugs. At the same time, we will establish a toolbox for future engineering high value advanced pharmaceutical ingredients.

www.topcapi.eu

 

 

 

 

MARPIPE - Improving the flow in the pipeline of the next generation of marine biodiscovery scientists

Funded by: European Commission Horizon 2020 - MSCA-ITN-ETN, Ref: 721421; Duration: 48 months

MarPipe is a consortium of 11 partners (IBP-CNR, SZN, UiT, UNIABDN, GEOMAR, KULeuven, UCC, eCOAST, MEDINA, MicroDish, Italbiotec) based in 8 countries (I, N, UK, D, B, IRL, E, NL), including 3 from the non-academic sector. MarPipe aims at further development of antimicrobial and anticancer lead compounds originating from a previous EU project (PharmaSea), and will also explore the bioactivity of deep-sea samples (5000m) collected during the recent Eurofleet-2 project in the sub-Antarctic.

www.marpipe.eu

 

OCEAN MEDICINES - Stimulating innovation by means of cross-fertilisation of knowledge

Funded by: European Commission H2020-EU.1.3.3. - Project reference: 690944 - Duration: 01/12/ 2015 to 30/11/2019

Ocean Medicines, a network of academic, research centres and SMEs across Europe, aims to establish a network of collaboration and knowledge-exchange between industrial and academic partners to further develop lead compounds from marine microorganisms having anticancer or anti-infective effects that have already been identified by the consortium.

http://cordis.europa.eu/project/rcn/198834_en.html

ocean medicines

 

 

 

Determination of metabolomics profiles for the diagnostic of breast cancer

Funded by the Ministry of Economy and Competitiveness of the Governement of Spain. CONVOCATORIA RETOS-COLABORACIÓN 2016-5674-1

Lead by ATRYS HEALTH S.A. , participants: ATRYS HEALTH S.A. , MEDINA, FIBAO.

MINCOMP

 

 

 

BLUE AND GREEN - Marine Biotechnology

Funding: European Union’s Horizon 2020 research and innovation programme under grant agreement No 692419.

BLUEandGREEN aims to increase the performance of CIIMAR in the area of Marine Biotechnology, and joins CIIMAR with four internationally-leading counterparts at the EU level: the University of Helsinki - Finland, the University of Bergen - Norway, GEOMAR, Helmholtz Centre for Ocean Research Kiel – Germany, and Fundación MEDINA - Spain.

bluegreenlogoeu22

 

 

 

ENABLE - European Gram Negative Antibacterial Engine

Funded by: Innovative Medicines Iniciative (IMI)- New Drugs for Bad Bugs ND4BB Duration: 2013-2018

http://www.imi.europa.eu

emiepfia

MICROSMETICS - Exploitation of microbial biodiversity for the discovery and development of novel cosmeceutical agents

Funded by: European Union FP7-PEOPLE-2013-IAPP under grant agreemet nº 612276 Duration: 2013-2017

http://www.microsmetics.eu

micrsmeticsand cologoeu22

 

 

Impacto en salud pública de la dispersión de enterobacterias productoras de carbapenemasas en España: Caracterización molecular de las cepas circulantes

Funded by: under agreement nº PI12/0242 Duration: 2013-2015

http://www.isciii.es

isciiipj

PharmaSea - Value Flow in the Marine Biodiscovery Pipeline

Funded by: European Union FP7-KBBE-2012-6-singlestage under grant agreemet nº 312184 Duration: 2012-2015

http://www.pharma-sea.eu

pharma7th

ParaMet - An analysis of parasite metabolism-from metabolism to intervention

Funded by: European Union FP7-PEOPLE-2011-ITN under grant agreemet nº 290080 - 2012-2015

http://www.paramet.eu

PARAMETEU

COCULMICRO - Cocultivation of microorganisms as a strategy for discovery of new natural products with antimicrobial properties

Funded by: European Union FP7-PEOPLE-2011-CIG Marie Curie Support for Training & Career develoment of researchers under grant agreement nº PCIG09-GA-2011-293992 - 08/2011-07/2015

logoeu22

 

 

 

DOSYMNPS - Novel applications of diffusion NMR spectroscopy in microbial natural products research

Funded by: European Union FP7-PEOPLE-2011-CIG Marie Curie Support for Training & Career develoment of researchers under grant agreement nº PCIG09-GA-2011-293762 - 09/2011-08/2015

http://cordis.europa.eu/project/rcn/99978_en.html

logoeu22

 

 

 

Descubrimiento de nuevos antibicoticos mediante la combinación de dos estrategias: cultivo de bacterias no cultivadas previamente y muestreo de hábitats salinos de Andalucía

Funded by: Regional Government of Andalucía. Project in Scientific Excellence under grant agreement nº CTS-5859 - 2011-2013

http://www.juntadeandalucia.es

JUNTA ANDALUCIA

Descubrimiento y desarrollo de nuevos antibióticos frente a bacterias gram negativas multiresistentes y de fármacos potenciadores de la actividad de carpabenems

Funded by: Regional Government of Andalucía. Project in Scientific Excellence under grant agreement nº CVI-6909 - 2011-2013

http://www.juntadeandalucia.es

JUNTAUGR

Antibiotics against multiresistant Gram negative pathogens and potentiators of carbapenem activity

Funded by: Research In Health Sciences Program, Health Sciences Institute Carlos III under grant agreement nº PI10/00745 - 2011-2013

http://www.isciii.es

isciiipj

Use of zebrafish as experimental model: evaluation of mithocondrial disfunction and identification of neuroprotective compounds from microbial natural in collaboration with The University of Granada

Funded by: Regional Government of Andalucía. Project in Scientific Excellence under grant agreement nº CTS-5784

http://www.juntadeandalucia.es

JUNTAUGR

Equipamiento complementario de alto rendimiento para el aislamiento y caracterización de Productos Naturales Bioactivos

Funded by: Spanish Ministry of Science and Innovation under grant agreement INP-2011-0016-PCT-010000-ACT6 - 2011

http://www.mineco.gob.es/

ministeriocienciainov

Discovery and characterization of new antibiotics by culturing previously uncultured bacteria

Funded by: Spanish Ministry of Science and Innovation. Non-Oriented Basic Research Project under grant agreement nº SAF2010-15010 - 2011-2013

http://www.mineco.gob.es

ministeriocienciainov

Búsqueda de Nuevos Antibacterianos y Caractericación de la Librería de Productos Naturales de la Fundación MEDINA

Funded by: Ministerio de Ciencia e Innovación dentro de los Presupuestos Generales del Estado para el 2010 aplicación presupuestaria 21.03.463B.789.01 - 2010

http://www.mineco.gob.es

ministeriocienciainov

Discovery and development of pharmaceuticals efficacious for amyotrophic lateral sclerosis (Lou Gerhig´s Disease)

Funded by: Ministry of Science and Innovation under grant agreement: PPT-300000-2009-2011

http://www.idi.mineco.gob.es

ministeriocienciainov

AntiFun: The cell wall as a target to improve antifungal therapy against Aspergillosis

Funded by: ERA-NET: Pathogenomics (7th FP) - 2009-201

https://www.pathogenomics-era.net

eraneteu

CONSOLIDER-INGENIO 2010: Discovery of novel antimicrobials from the Metagenome of the Iberian Peninsula

Funded by: Spanish Ministry of Science and Innovation - 2008-2012

http://www.idi.mineco.gob.es/

ministeriocienciainov